SCHEMBL679992

SCHEMBL679992

O=C(O)c1cc2cccnc2c2ncccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.60
L3MBTL1 Q9Y468 5/20 0.58
KDM4A O75164 2/20 0.58
EGLN1 Q9GZT9 2/20 0.58
TET2 Q6N021 2/20 0.58
TET1 Q8NFU7 2/20 0.58
KDM6B O15054 1/20 0.58
KDM6A O15550 1/20 0.58
TET3 O43151 1/20 0.58
KDM4B O94953 1/20 0.58
KDM5C P41229 1/20 0.58
KDM4D Q6B0I6 1/20 0.58
ALKBH5 Q6P6C2 1/20 0.58
FTO Q9C0B1 1/20 0.58
KDM4C Q9H3R0 1/20 0.58
KDM2A Q9Y2K7 1/20 0.58
KDM3A Q9Y4C1 1/20 0.58
CCR1 P32246 2/20 0.54
CCR8 P51685 2/20 0.54
ALDH1A1 P00352 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10611260 0.88 KDM4E (0.59) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL5071691 0.86 KDM4E (0.50) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL8674711 0.86 KDM4E (0.54) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL29089092 0.85 PARP1 (0.60) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL11907463 0.85 CCR1 (0.57) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL5069000 0.85 KDM4E (0.52) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL17174167 0.84 KDM4E (0.49) KDM4EL3MBTL1KDM4AEGLN1TET2
Acetic Acid SCHEMBL3191395 0.83 PARP1 (0.54) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL27558406 0.82 L3MBTL1 (0.50) KDM4EL3MBTL1KDM4AEGLN1TET2
SCHEMBL31316501 0.81 ALDH1A1 (0.61) KDM4EL3MBTL1KDM4AEGLN1TET2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118755473-B Probe for specifically detecting type I collagen and detection method 天津包钢稀土研究院有限责任公司 2024-12-06 CN claimed
CN-118755473-A Probe for specifically detecting type I collagen and detection method 天津包钢稀土研究院有限责任公司 2024-10-11 CN claimed
EP-4405369-A2 A CIS-PLATINUM(II)-OLIGOMER HYBRID Dublin City University (IE) 2024-07-31 EP claimed
CN-118221709-A Method for synthesizing N-Boc piperidine boric acid ester with high yield 上海予君生物科技发展有限公司 2024-06-21 CN claimed
CN-118103385-A Cis-platinum (II) oligomer hybrids 都柏林城市大学 2024-05-28 CN claimed
CN-114277026-B Magnetic bead for nucleic acid extraction, preparation method thereof and kit for nucleic acid extraction by magnetic bead method 深圳市易瑞生物技术股份有限公司 2023-07-14 CN claimed
WO-2023046875-A2 A CIS-PLATINUM(II)-OLIGOMER HYBRID DUBLIN CITY UNIVERSITY (IE) 2023-03-30 WO claimed
CN-110563889-B Rare earth modified acrylic acid copolymerization waterborne alkyd resin and preparation method thereof 合众(佛山)化工有限公司 2022-05-03 CN claimed
CN-114277026-A Magnetic bead for nucleic acid extraction, preparation method thereof and kit for magnetic bead method nucleic acid extraction 深圳市易瑞生物技术股份有限公司 2022-04-05 CN claimed
CN-110577784-A Rare earth modified acrylic acid copolymer waterborne alkyd resin coating 合众(佛山)化工有限公司 2019-12-17 CN claimed
CN-110563889-A Rare earth modified acrylic acid copolymerization waterborne alkyd resin and preparation method thereof 合众(佛山)化工有限公司 2019-12-13 CN claimed
CN-118755473-B Probe for specifically detecting type I collagen and detection method 天津包钢稀土研究院有限责任公司 2024-12-06 CN disclosed
CN-118755473-B Probe for specifically detecting type I collagen and detection method 天津包钢稀土研究院有限责任公司 2024-12-06 CN disclosed
US-20240382602-A1 A CIS-PLATINUM(II)-OLIGOMER HYBRID DUBLIN CITY UNIVERSITY (IE) 2024-11-21 US disclosed
CN-118755473-A Probe for specifically detecting type I collagen and detection method 天津包钢稀土研究院有限责任公司 2024-10-11 CN disclosed
US-20060210914-A1 Positive photoresist composition and method of forming resist pattern TOKYO OHKA KOGYO., LTD. (JP) 2006-09-21 US disclosed
US-20060183048-A1 Positive photoresist composition and resist pattern formation TOKYO OHKA KOGYO CO., LTD. (JP) 2006-08-17 US disclosed
US-20060166131-A1 Positive photoresist composition and method of forming resist pattern TOKYO OHKA KOGYO, CO., LTD. (JP) 2006-07-27 US disclosed
EP-1644427-A2 POSITIVE PHOTORESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2006-04-12 EP disclosed
WO-2005007719-A2 POSITIVE PHOTORESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2005-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240382602-A1 A CIS-PLATINUM(II)-OLIGOMER HYBRID PCNA, DCLRE1A, LIG4 KDM4E 4861/4885L3MBTL1 520/4885KDM4A 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.